These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11498183)

  • 1. Panel-reactive antibodies using complement-dependent cytotoxicity, flow cytometry, and ELISA in patients awaiting renal transplantation or transplanted patients: a comparative study.
    Mansour I; Messaed C; Azoury M; Klayme S; Naaman R
    Transplant Proc; 2001 Aug; 33(5):2844-7. PubMed ID: 11498183
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation.
    Rebibou JM; Chabod J; Bittencourt MC; Thévenin C; Chalopin JM; Hervé P; Tiberghien P
    Transplant Proc; 2000 Dec; 32(8):2745-6. PubMed ID: 11134783
    [No Abstract]   [Full Text] [Related]  

  • 3. A complementary strategy for pretransplant HLA antibody screening.
    Tiercy JM; Cattin S; Pongratz G; Goumaz C; Villard J
    Transplant Proc; 2002 May; 34(3):850-1. PubMed ID: 12034207
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study.
    Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C
    Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the median channel shift in the flow cytometry for predicting complement dependent cytotoxicity crossmatching in kidney transplant candidates.
    de Moraes P; Fagundes I; Cardone JM; Gil BC; Kulzer ASS; Hadi RA; Manfro RC; Jobim LF
    Transpl Immunol; 2019 Feb; 52():27-31. PubMed ID: 30367965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies.
    Sumitran-Karuppan S; Moller E
    Transplantation; 1996 May; 61(10):1539-45. PubMed ID: 8633385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques.
    Papassavas AC; Iniotaki-Theodoraki A; Stathakopoulou A; Ioannou S; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 1998 May; 30(3):724-6. PubMed ID: 9595073
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.
    Ettenger R; Cho S; Marik J; von Lilien T; Fine RN
    Transplant Proc; 1987 Feb; 19(1 Pt 1):740-2. PubMed ID: 3274859
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA antibodies: detection and effect on renal transplant function.
    Koka P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):243-4. PubMed ID: 8438286
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [METHODS FOR DETECTION OF ANTIBODIES TO HLA ANTIGENS IN PATIENTS AWAITING KIDNEY TRANSPLANTATION AND COMBINED PANCREAS-KIDNEY TRANSPLANTATION].
    Ančić M; Maravić B; Radman M; Kovačić V
    Acta Med Croatica; 2014 Dec; 68(4-5):421-3. PubMed ID: 26285477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.